In vivo tracking of stem cells for clinical trials in cardiovascular disease

John V. Frangioni, Roger J. Hajjar

Research output: Contribution to journalArticlepeer-review

230 Scopus citations

Abstract

Various stem cells hold promise for the treatment of human cardiovascular disease. Regardless of stem cell origin, future clinical trials will require that the location and number of such cells be tracked in vivo, over long periods of time. The problem of tracking small numbers of cells in the body is a difficult one, and an optimal solution does not yet exist. We review the many contrast agents and detectors that have been proposed for stem cell tracking during clinical trials, define the characteristics of an ideal imaging technology, and suggest future directions for research.

Original languageEnglish
Pages (from-to)3378-3383
Number of pages6
JournalCirculation
Volume110
Issue number21
DOIs
StatePublished - 23 Nov 2004
Externally publishedYes

Keywords

  • Imaging
  • Radiology
  • Stem cells
  • Trials

Fingerprint

Dive into the research topics of 'In vivo tracking of stem cells for clinical trials in cardiovascular disease'. Together they form a unique fingerprint.

Cite this